Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs EL✓SelectedUSD · ELGSK vs EL performance historyLatest closeAs of-1.56%11/19
Stock and ETF performance explorer

GSK vs EL

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+40.3%
EL return
-68.6%
Excess return
+108.9%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioELExcessAlpha
1D-1.6%-2.2%+0.6%-1.4%
7D-4.7%-7.9%+3.2%-4.0%
30D-4.7%-4.1%-0.6%-4.3%
3M-8.8%+4.2%-12.9%-9.2%
6M-4.6%+34.6%-39.3%-7.4%
YTD+1.0%-1.8%+2.8%+0.2%
1Y+6.9%+20.1%-13.3%+3.9%
3Y+52.5%-13.1%+65.7%+48.8%
5Y+40.3%-68.8%+109.1%+53.0%
All+40.3%-68.6%+108.9%+53.0%

Cumulative growth

Daily Returns

Daily percentage return beside EL.

Daily Out/Under-Performance

Portfolio return minus EL return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × EL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded EL wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling